← Leaderboards
Caitlin Rosemary Hopkins
University Of Pennsylvania
$130,976
Attributed
$130,976
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.7K · FY2022–24$50K$37.5K$25K$12.5K$0
'22
'23
'24
Funding mix
By agency
NIH$130,976 · 1
By mechanism
F31$130,976 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Carl H. June$35,377,952
- James L Riley$56,591,102
- Robert H Vonderheide$28,425,019
- Frank S Lee$12,269,170
- Steven Mark Albelda$22,046,338
Others in their field
Other Rising Stars on “Atac-Seq”
- Linus Tzu-Yen Tsai · Beth Israel Deaconess Medical Center$3,279,626
- Sarah Elizabeth Lutz · University Of Illinois At Chicago$3,110,235
- Ming He · University Of California, San Diego$2,917,239
- Konstantinos Chronis · University Of Illinois At Chicago$2,889,628
- Yue Wang · Florida State University$2,782,476
- Andrew Chris Yang · University Of California, San Francisco$2,531,012
Research focus
Atac-SeqAutologousBaseBase Excision RepairsB-Cell Acute Lymphoblastic LeukemiaBiologicalB Lymphoid MalignancyCancer CellCancer PatientCar T Cell TherapyCd19 GeneCd8-Positive T-LymphocytesCell Differentiation ProcessCell ExtractsCell PhysiologyCellsCell TherapyCell TypeCellular ImmunotherapyChemotherapyChimeric Antigen ReceptorChimeric Antigen Receptor T CellsChip-SeqAntigens
Grant awards (3)
Mechanisms of TET2-dependent control of CAR T cell fate determination and antitumor function$36,530
F31 · FY2024 · CA · contact PI
Mechanisms of TET2-dependent control of CAR T cell fate determination and antitumor function$47,694
F31 · FY2023 · CA · contact PI
Mechanisms of TET2-dependent control of CAR T cell fate determination and antitumor function$46,752
F31 · FY2022 · CA · contact PI